Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca to acquire Fusion for approximately $2bn

March 19, 2024
Business Services AstraZeneca, Fusion Pharmaceuticals, Oncology, acquisition, radioconjugates

AstraZeneca has announced that it has entered into a definitive agreement to acquire Fusion Pharmaceuticals for an approximate $2bn. This …

News

GSK shares data from phase 3 trial for Jemperli combinations for endometrial cancer treatment

March 18, 2024
Research and Development GSK, Jemperli, Oncology, clinical trial, endometrial cancer, women's health

GSK has announced positive results from part 1 and part 2 of its RUBY/ENGOT-EN6/GOG3031/NSGO phase 3 trial for Jemperli (dostarlimab) …

News

Merck shares results for Keytruda in cervical cancer treatment

March 18, 2024
Research and Development Merck, Oncology, cervical cancer, keytruda, women's health

Merck, known as MSD outside of the US and Canada, has announced positive results from the phase 3 KEYNOTE-A18 trial, …

News

Allumiqs and Prolytix enter partnership for acceleration of drug discovery and development

March 15, 2024
Research and Development Allumiqs, Pharmacy, drug discovery, partnership

Allumiqs and Prolytix have announced that they have entered into a long-term, strategic partnership with the aim of providing collaboratinve …

News

FDA approves first treatment for liver scarring due to fatty liver disease

March 15, 2024
Medical Communications Endocrinology, FDA, fatty liver disease, liver scarring, nash

The US Food and Drug Administration (FDA) has announced that it has approved Rezdiffra (resmetirom) for the treatment of adult …

News

AstraZeneca to acquire Amolyt Pharma for up to $1.05bn

March 14, 2024
Business Services Amolyt Pharma, AstraZeneca, Rare Diseases, acquisition, rare diseases

AstraZeneca has announced that it has entered into a definitive agreement under which it will acquire Amolyt Pharma for up …

News

Bayer and Aignostics to collaborate for AI oncology research

March 14, 2024
Research and Development AI, Bayer, Oncology, research

Bayer and Aignostics have announced that they have entered into a strategic collaboration for several artificial intelligence (AI)-powered approaches for …

News

EC approves Pfizer’s Prevenar 20 to protect paediatric patients against pneumococcal disease

March 13, 2024
Research and Development EC, EMA, Infections and infestations, Prevnar 20, pneumococcal disease

Pfizer has announced that the European Commission (EC) has granted marketing authorisation for Prevenar 20, the company’s 20-valent pneumococcal conjugate …

News

Merck plans to conduct trials for HPV vaccines

March 13, 2024
Research and Development Immunology, Merck, vaccines

Merck, known as MSD outside of the US and Canada, has announced that it is planning to initiate clinical development …

News

Sanofi shares phase 2b results for dermatitis treatment

March 12, 2024
Research and Development Dermatology, Sanofi, amlitelimab, atopic dermatitis, clinical trial, dermatitis

Sanofi has shared positive results from part 2 of the investigational phase 2b STREAM-AD study of amlitelimab for adult patients …

News

Merck completes acquisition of Harpoon Therapeutics for $650m

March 12, 2024
Business Services Harpoon Therapeutics, Merck, Oncology, lung cancer

Merck, known as MSD outside of the US and Canada, has announced that it has completed the acquisition of Harpoon …

News

Johnson & Johnson acquires Ambrx Biopharma for approximately $2bn

March 11, 2024
Business Services ADCs, Ambrx Biopharma, J&J, Johnson & Johnson, Oncology, acquisition

Johnson & Johnson (J&J) has announced that it has successfully completed its acquisition of Ambrx Biopharma in an all-cash merger …

News

Aspire Pharma acquires Cenoté Pharma

March 11, 2024
Business Services Aspire Pharma, Cenoté Pharma, Pharmacy, acquisition

Aspire Pharma has announced that it has successfully acquired Cenoté Pharma as part of its plan to supplement its growth …

News

BeiGene’s Brukinsa gains FDA accelerated approval for follicular lymphoma treatment

March 8, 2024
Medical Communications BeiGene, Brukinsa, FDA, Oncology, follicular lymphoma

BeiGene has announced that the US Food and Drug Administration (FDA) has granted accelerated approval to Brukinsa (zanubrutinib) for the …

News

Roche shares data on novel solution for continuous glucose monitoring

March 8, 2024
Research and Development Diabetes, Medical device, Roche, continuous glucose monitoring, diabetes

Roche has shared the latest data on its novel solution for continuous glucose monitoring (CGM), including a CGM sensor and …

News

GSK shares results from phase 3 trial for Blenrep for treatment of multiple myeloma

March 7, 2024
Research and Development Blenrep, GSK, Oncology, clinical trial, multiple myeloma

GSK has announced positive results from an interim analysis of the DREAMM-8 phase 3 head-to-head trial which assesses Blenrep (belantamab …

News

Gilead and Merck share data from phase 2 trial of HIV treatment

March 7, 2024
Research and Development Gilead Sciences, HIV, HIV/AIDS, Merck, clinical trials

Gilead Sciences and Merck (known as MSD outside of the US and Canada) have announced results from the phase 2 …

News

Measles: the UK’s next epidemic?

March 6, 2024
MMR, measles, vaccines

Recently, the UK has seen a rapid increase in the number of cases of measles, along with a drop in …

Feature

FDA approves Sandoz’s denosumab biosimilars

March 6, 2024
Medical Communications FDA, Jubbonti, Musculo-skeletal disorder, Sandoz, Wyost, denosumab

Sandoz has announced that the US Food and Drug Administration (FDA) has approved Wyost (denosumab-bbdz) and Jubbonti (denosumab-bbdz), which are …

News

Regenxbio announces initial efficacy data from phase 1/2 AFFINITY DUCHENNE trial

March 6, 2024
Research and Development Duchenne Muscular Dystrophy, Musculo-skeletal disorder, Regenxbio, clinical trial

Regenxbio has announced additional interim safety data from its phase 1/2 AFFINITY DUCHENNE trial of RGX-202 in patients with Duchenne …

News

Latest content

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024

Pfizer’s Beqvez approved by FDA for haemophilia B treatment

April 29, 2024